Newbridge Financial Services Group, Inc. Ionis Pharmaceuticals Inc Transaction History
Newbridge Financial Services Group, Inc.
- $372 Million
- Q4 2024
A detailed history of Newbridge Financial Services Group, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 200 shares of IONS stock, worth $5,940. This represents 0.0% of its overall portfolio holdings.
Number of Shares
200Holding current value
$5,940% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IONS
# of Institutions
409Shares Held
132MCall Options Held
829KPut Options Held
789K-
Vanguard Group Inc Valley Forge, PA16.5MShares$489 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$421 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$341 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$307 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$234 Million5.48% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.22B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...